Table 1 Clinicopathological characteristics of patients who were planned to receive robotic-assisted SPDP with splenic vessels preservation

Age, years, median, (IQR)

46 (35–56)

49 (32–62)

46 (35–56)

0.788^a

Sex, male, n, (%)

25 (33.8%)

6 (37.5%)

19 (32.8%)

0.723^b

BMI, kg/m², median, (IQR)

24.0 (20.9–25.7)

23.2 (19.7–24.6)

24.6 (21.1–25.9)

0.162^a

ASA classification I-II, n, (%)

62 (83.8%)

14 (87.5%)

48 (82.8%)

1.000^c

Tumor size, cm, median, (IQR)

2.5 (1.6-4.0)

2.5 (2.0–4.0)

2.4 (1.5-4.0)

0.566^a

Pathology, n, (%)

0.183^c

Pancreatic neuroendocrine tumor

40 (54.1%)

8 (50.0%)

32 (55.2%)

 Intraductal papillary mucinous neoplasm

5 (6.8%)

1 (6.3%)

4 (6.9%)

 Mucinous cystic adenoma

3 (4.1%)

2 (12.5%)

1 (1.7%)

 Solid pseudopapillary neoplasm

9 (12.2%)

0 (0%)

9 (15.5%)

 Serous cystic adenoma

13 (17.6%)

4 (25.0%)

9 (15.5%)

 Others

4 (5.4%)

1 (6.3%)

3 (5.2%)